All Posts By

Smartkarma Daily Briefs

Daily Brief Equity Bottom-Up: Tesla Q4 Miss Is Big & Sets the Stage for a Drop in 2023 Profits and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • Tesla Q4 Miss Is Big & Sets the Stage for a Drop in 2023 Profits
  • ASML & Lam Results: Key Take-Aways for Semiconductors in 2023
  • Hyundai Motor: Solid Earnings in 4Q 2022 + Shares Cancellation
  • Hindustan Unilever (HUVR IN) | Royalty Rukus
  • S&P (SPGI US) VS S&P (SPX Index): A Leveraged Play on Rate Expectations
  • Technical Analysis On Exxon Mobil
  • Record Sales at JR Tokai Takashimaya
  • HYDB: Optimistically Backing High-Yield Corporate Bonds
  • Itochu Signs L.L.Bean License, Gears up Forever 21 and Eddie Bauer Relaunches
  • UI: Inventory Environment

Tesla Q4 Miss Is Big & Sets the Stage for a Drop in 2023 Profits

By SC Capital

  • Tesla reported a 6% Q4 EPS beat, but stripping out a one-off deferred revenue booking & higher than expected regulatory credits, Q4 results missed by 9%.  
  • Tesla rose +5.5% post market close after Musk said YTD orders are “2x” output. None of the data we have seen implies such demand, especially weekly China sales. 
  • What went unnoticed on the earnings call is that Tesla created a $7bn credit facility this month, which should dash all hopes of them doing a share buyback in 2023. 

ASML & Lam Results: Key Take-Aways for Semiconductors in 2023

By Vincent Fernando, CFA

  • ASML and Lam Research’s latest guidance implies extremely different near-term revenue outlooks but shows an industry pulling back near-term while investing for long-term.
  • Results show the much weaker situation for Memory chips vs. Logic chips, and little discussion of a recovery for Memory from the firms so far.
  • Firms servicing long-term strategic, specialized demand from customers are indeed performing better than those servicing more commoditized demand.

Hyundai Motor: Solid Earnings in 4Q 2022 + Shares Cancellation

By Douglas Kim

  • Hyundai Motor’s EV sales as a percentage of total sales increased from 4.3% in 4Q 2021 to 5.7% in 4Q 2022. 
  • Hyundai Motor announced that it will cancel 2.14 million common shares, representing 1% of its outstanding common shares.
  • The company beat consensus sales and operating profit estimates in 4Q 2022 and the consensus is likely to revise up their earnings estimates. 

Hindustan Unilever (HUVR IN) | Royalty Rukus

By Pranav Bhavsar

  • Hindustan Unilever (HUVR IN)‘s strong quarterly performance was overshadowed by a proposed hike in royalty payments to parent Unilever PLC (ULVR LN) 
  • HUVR’s historical royalty growth has been below revenue and PBT growth and hence does not generate any red flags in terms of minority shareholder protection.  
  • While the impact on EPS is ~3%, we believe much of the reaction around HUVR’s Royalty is Noise. 

S&P (SPGI US) VS S&P (SPX Index): A Leveraged Play on Rate Expectations

By Stanley Tsai, CFA

  • S&P (the company) may be a lot more exposed than S&P (the index) if rates stay higher for longer and bets against the Fed unwind in 2H23.
  • While we like the rating agency and financial data provider’s business portfolio, valuation is looking a bit stretched based on fundamental, relative and technical valuation metrics.
  • We believe it is unlikely that the stock will push through the USD375/share resistance level in the near term, and would look for entry opportunities closer to USD325/share.

Technical Analysis On Exxon Mobil

By VRS (Valuation & Research Specialists)

  • Exxon Mobil Corporation is engaged in energy business. The Company’s principal business involves the exploration for, and production of, crude oil and natural gas, and the manufacture, trade, transport and sale of crude oil, natural gas, petroleum products, petrochemicals and a range of specialty products.
  • The Company’s segments include Upstream, Downstream and Chemical.
  • The Upstream segment is organized and operates to explore for and produce crude oil and natural gas.

Record Sales at JR Tokai Takashimaya

By Michael Causton

  • JR Takashimaya is a newbie in the world of department store retailing but has grown to become the fourth highest selling store in the two decades since it opened. 
  • As a result, it is increasingly regarded by brands as the Nagoyan version of Isetan Shinjuku in Tokyo and Hankyu Umeda in Osaka.
  • The store is an example of Takashimaya’s successful strategy to surround its key stores with more shopping facilities to suit all population segments, so driving traffic to the main store.

HYDB: Optimistically Backing High-Yield Corporate Bonds

By Pearl Gray Equity and Research

  • We might get a reasonable amount of flak for this article, as many investors fear a recession, and concurrently are staying away from high-yield bonds.

  • However, credit spreads are narrowing, and the equity market is receiving substantial support.

  • Thus, we believe the


Itochu Signs L.L.Bean License, Gears up Forever 21 and Eddie Bauer Relaunches

By Michael Causton

  • Three years ago, Itochu Corp made it clear it would be investing heavily in its brand business.
  • It has been true to its word, adding the likes of Reebok, Under Armour and Forever 21 to its portfolio in the last year alone.
  • It has now signed a deal with long-term Japan operator, L.L.Bean, while gearing up for a major relaunch of Eddie Bauer.

UI: Inventory Environment

By Hamed Khorsand

  • The enterprise segment has fueled revenue growth at Ubiquiti (UI) and it should remain the same in the fiscal second quarter
  • Ubiquiti has expanded its product offering for enterprise customers where it includes a complete solution down to the EV charging station
  • We have made several adjustments to our earnings model. We continue to assume gross margin rising sequentially due to lower costs

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Industrials: Adani Enterprises, SATS, Caverion Corp, Airbus Group SE and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Adani Enterprises FPO Update:  Hindenburg, Anchors, and Righteous Indignation
  • Quiddity Leaderboard for Straits Times Index Mar 23: SMM Could Miss Addition
  • North Holdings 3/​Caverion: Fair Enough
  • Airbus: Early-Stage Revenue, Margin, and Cashflow Recovery

Adani Enterprises FPO Update:  Hindenburg, Anchors, and Righteous Indignation

By Travis Lundy

  • The Adani Enterprises (ADE IN) Further Public Offering (“FPO”) expected to raise Rs 200bn has its first leg publicly complete with anchor investors taking Rs 59.849bn. 
  • Noted shortseller Hindenburg Research published a long report suggesting Adani Enterprises and indeed the Adani Group were over-priced according to fundamentals and were the result of  a “con.”
  • Now the book build starts. Deal structure and Adani Group CFO comments continue to suggest that Liquidity is a Bug, not a Feature.

Quiddity Leaderboard for Straits Times Index Mar 23: SMM Could Miss Addition

By Janaghan Jeyakumar, CFA

  • In this insight, we take a look at the potential index changes for the FTSE Straits Times Index (STI) (STI INDEX) between now and the March 2023 index review.
  • Previously, I expected the Sembcorp Marine (SMM SP)Keppel Corp (KEP SP) deal to complete in time for SMM to be added to STI during the March 2023 review.
  • However, that is looking less likely. SMM’s addition could get delayed to June 2023 and there might be a longer-period overhang in SMM once the deal completes.

North Holdings 3/​Caverion: Fair Enough

By Jesus Rodriguez Aguilar

  • The Bain’s consortium announced an agreed sweetened offer (Alternative Consideration, shares exchanged for a zero-coupon debt instrument redeemable at €8.5 by mid-December), 6.25% premium to Triton’s offer.
  • The Alternative Consideration (illiquid) corresponds to 16.3x EV/Fwd EBIT and 19.3x Fwd P/E. There are high chances that the bidding process will stop, but would still be long the shares.
  • The Bain’s consortium has now all regulatory approvals. Gross spread is 0.82%, with an estimated annual return of 0.90% assuming settlement of the Alternative Consideration Instrument by 29 December.

Airbus: Early-Stage Revenue, Margin, and Cashflow Recovery

By Alexis Dwek

  • As air traffic improves, the combination of increased production rates and strong price increases should partly offset supply related costs.
  • The Company’s FCF levels further improve as margins recover, inventory delivered, and pre-payments received
  • The share buyback program will resume once €10bn of free cash flow is generated. Airbus is a high-quality Company with a strong management team in place.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Event-Driven: IDX30/​​LQ45/IDX80 Index Rebalance: 4 Days to Implementation and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • IDX30/​​LQ45/IDX80 Index Rebalance: 4 Days to Implementation
  • SenseTime (20 HK): Index Inclusions Incoming?
  • Northbound Stock Connect Expansion: Updated Details
  • JAFCO Tender Offer Results – Low Pro-Ration Surprise, Murakami Overhang
  • Adani Enterprises FPO Update:  Hindenburg, Anchors, and Righteous Indignation
  • Acotec (6669 HK): Boston Scientific’s HK$20 Partial Offer Unconditional
  • Where To Go With Warrego?
  • AAG Energy (2686 HK): Is Xinjiang Xintai Returning for Another Bid?
  • Xingda (1899 HK): HK$1.88 Partial Offer Now Open
  • Nitto Denko Q3 Results and Buyback Announced

IDX30/​​LQ45/IDX80 Index Rebalance: 4 Days to Implementation

By Brian Freitas

  • There are 3 changes for the IDX30 Index, 6 changes for the LQ45 Index, and 7 changes for the IDX80 Index at the rebalance to be implemented on 31 January.
  • Largest passive inflows are expected to be on Sumber Alfaria Trijaya Tbk Pt (AMRT IJ) and Surya Esa Perkasa (ESSA IJ)
  • With only 4 days to implementation, there will be relatively big moves on stocks that have large flow/impact from passive fund trading.

SenseTime (20 HK): Index Inclusions Incoming?

By Brian Freitas

  • SenseTime Group (20 HK) was added to the Non-SDN Chinese Military-Industrial Complex Company (NS-CMIC) list on 10 December 2021. So, the stock is not a part of any global indices.
  • There is a possibility that the stock is no longer restricted to U.S. investors and that could lead to multiple index inclusions over the next few months.
  • Inclusion in the MSCI China Index could take place in February or May while inclusion in the FTSE All-World Index could take place in March.

Northbound Stock Connect Expansion: Updated Details

By Brian Freitas

  • On 19 January, the HKEX clarified the liquidity criteria as well as treatment of Differentiated Voting Rights (DVR) stocks and the criteria for current Northbound stocks to become Sell-only.
  • We currently see 975 China A-shares becoming eligible for Northbound Stock Connect when the extension is implemented.
  • With the extension likely to be implemented in June, there will be additions to the MSCI China Index, FTSE All-World Index and FTSE All-Cap Index in August and September.

JAFCO Tender Offer Results – Low Pro-Ration Surprise, Murakami Overhang

By Travis Lundy

  • Jafco Co Ltd (8595 JP) announced the results of its Tender Offer Buyback today. They wanted to buy 16.8mm shares including 13.9mm from Murakami-san. He sold 9.63mm. Oops. 
  • Pro-Ration was 69.25% which means that Murakami entities are still long about 4.276mm shares or 5.83% of shares out. 
  • There should be some index selling, and some Murakami Overhang. There may be more overhang at recent prices.

Adani Enterprises FPO Update:  Hindenburg, Anchors, and Righteous Indignation

By Travis Lundy

  • The Adani Enterprises (ADE IN) Further Public Offering (“FPO”) expected to raise Rs 200bn has its first leg publicly complete with anchor investors taking Rs 59.849bn. 
  • Noted shortseller Hindenburg Research published a long report suggesting Adani Enterprises and indeed the Adani Group were over-priced according to fundamentals and were the result of  a “con.”
  • Now the book build starts. Deal structure and Adani Group CFO comments continue to suggest that Liquidity is a Bug, not a Feature.

Acotec (6669 HK): Boston Scientific’s HK$20 Partial Offer Unconditional

By Arun George

  • As expected, Acotec Scientific Holdings (6669 HK)’s partial offer from Boston Scientific (BSX US) at HK$20 per share is now unconditional. The final closing date is 9 February.
  • The current acceptances representing 78.59% of outstanding shares imply current proration is 82.71%. Current pro-ration suggests CA Medtech post-offer shares will be counted towards the public float.
  • Based on the current proration of 82.71% and at the last close price of HK$19.78 per share, the breakeven price is HK$19.00 per share. 

Where To Go With Warrego?

By David Blennerhassett

  • It’s a fair bet Hancock Prospecting and Mineral Resources (MIN AU) are actively discussing the final stages for Warrego Energy (WGO AU) behind the scenes.
  • It is unlikely MinRes aggressively builds a ~19% stake in a company subject to a two-way takeover battle, and declares its position “strategic” with no intention of making an Offer. 
  • This stake may be a bargaining chip from MinRes to keep Hancock on the sidelines in its tilt for Norwest Energy NL (NWE AU).

AAG Energy (2686 HK): Is Xinjiang Xintai Returning for Another Bid?

By Arun George

  • Aag Energy Holdings (2686 HK) entered a trading halt pending the release of an announcement under the Hong Kong Code on Takeovers and Mergers on 26 January. 
  • It is likely that Xinjiang Xintai Natural Gas (603393 CH), the largest shareholder representing 56.95% of outstanding shares is seeking to privatise AAG. 
  • The potential bid is likely privatisation through a scheme. Multiples from Xinjiang Xintai’s previous voluntary cash offer in 2018 suggest an offer north of HK$2.00. 

Xingda (1899 HK): HK$1.88 Partial Offer Now Open

By Arun George

  • Xingda International (1899 HK)’s partial offer from a management-controlled offeror at HK$1.88 per share is now open. The IFA opines it to be fair and reasonable.
  • The partial offer is conditional on the offeror/concert parties, which have a 45.60% stake, hitting 50.01% voting rights and approval by the requisite majority of shareholders on the acceptance form.
  • The 4.41% minimum acceptance is not onerous. Based on a proration of 8.88% and at the last close price of HK$1.59 per share, the breakeven price is HK$1.56 per share.

Nitto Denko Q3 Results and Buyback Announced

By Travis Lundy

  • Nitto Denko (6988 JP) today announced Q3 results, lower full-year guidance with one-quarter left to go, sharply undercutting implied Q4 results vs the Street.
  • The company also announced a buyback of 4.1-4.7% of shares out over the next 6mos. Assuming the share price falls in reaction, this could be closer to the top end.
  • The buyback is non-negligible as a portion of Likely Real World Float and as such the situation is worth a look – for those with a position and those without.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief TMT/Internet: SenseTime Group, Taiwan Semiconductor (TSMC) – ADR, Cellnex Telecom Sau, Ubiquiti Inc., MotorK Ltd, Harvest Technology Group Ltd, Acal PLC and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • SenseTime (20 HK): Index Inclusions Incoming?
  • ASML & Lam Results: Key Take-Aways for Semiconductors in 2023
  • AMT/Cellnex: Possible Combination?
  • UI: Inventory Environment
  • MotorK – Promising signs for 2023
  • HTG – EU Defence Force Needs Secure Communications
  • discoverIE Group – Better trading and acquisition drive upgrades

SenseTime (20 HK): Index Inclusions Incoming?

By Brian Freitas

  • SenseTime Group (20 HK) was added to the Non-SDN Chinese Military-Industrial Complex Company (NS-CMIC) list on 10 December 2021. So, the stock is not a part of any global indices.
  • There is a possibility that the stock is no longer restricted to U.S. investors and that could lead to multiple index inclusions over the next few months.
  • Inclusion in the MSCI China Index could take place in February or May while inclusion in the FTSE All-World Index could take place in March.

ASML & Lam Results: Key Take-Aways for Semiconductors in 2023

By Vincent Fernando, CFA

  • ASML and Lam Research’s latest guidance implies extremely different near-term revenue outlooks but shows an industry pulling back near-term while investing for long-term.
  • Results show the much weaker situation for Memory chips vs. Logic chips, and little discussion of a recovery for Memory from the firms so far.
  • Firms servicing long-term strategic, specialized demand from customers are indeed performing better than those servicing more commoditized demand.

AMT/Cellnex: Possible Combination?

By Jesus Rodriguez Aguilar

  • Press reported (20 January) that American Tower and Brookfield are preparing to launch a takeover bid for European towerco leader Cellnex with the intention of delisting the business.
  • Cellnex on 16.9x EV/22e EBITDA is trading cheaply vs AMT (21.6x) and a diversified unique asset. Its towers would come at €350,000/tower vs. recent deals at €500,000.
  • Top ten shareholders own 57.41%. The last rights issue was done at €36.33/share. At what price those shareholders could be bought out? Unlikely at less than a 25% premium, €45.5/share.

UI: Inventory Environment

By Hamed Khorsand

  • The enterprise segment has fueled revenue growth at Ubiquiti (UI) and it should remain the same in the fiscal second quarter
  • Ubiquiti has expanded its product offering for enterprise customers where it includes a complete solution down to the EV charging station
  • We have made several adjustments to our earnings model. We continue to assume gross margin rising sequentially due to lower costs

MotorK – Promising signs for 2023

By Edison Investment Research

For FY22, MotorK reported a record Q4, driven by its focus on higher-value enterprise contracts, the launch of its SparK platform and the continued migration of acquired companies onto the platform. Annualised recurring revenue (ARR), management’s main metric for tracking performance, was €26.9m, falling short of our €28m forecast and management’s guided range of €28–30m. FY23 and beyond looks set to benefit from a large pipeline of contract opportunities, with €5.2m of additional ARR committed as at 31 December 2022. Growth should be supported by maintaining low customer churn and high net revenue retention.


HTG – EU Defence Force Needs Secure Communications

By Research as a Service (RaaS)

  • Harvest Technology Group Limited (ASX:HTG) licenses its proprietary video compression and encryption technology for low-bandwidth, high-latency applications needing secure real-time streaming video communication.
  • The company delivers solutions for data transfer from anywhere via satellite or congested networks.
  • Harvest offers a solution which enables real-time monitoring of remote locations, real-time feedback for field technicians, and secure video conferencing. 

discoverIE Group – Better trading and acquisition drive upgrades

By Edison Investment Research

discoverIE’s Q323 trading update confirmed continued good momentum, with FY23 underlying earnings tracking ahead of board expectations. The company has completed the previously announced acquisition of Magnasphere, adding a high margin sensor business to the Sensing & Connectivity division. We have upgraded our forecasts to reflect better trading and the accretive acquisition and note that gearing remains below the company’s target range, providing headroom for further M&A.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Macro: Comment on Exchange Rate EUR/USD – December 30 and more

By | Daily Briefs, Macro

In today’s briefing:

  • Comment on Exchange Rate EUR/USD – December 30, 2022

Comment on Exchange Rate EUR/USD – December 30, 2022

By VRS (Valuation & Research Specialists)

  • The EUR/USD exchange rate has been moving upwards, as seen in Graph 1. There were four secondary movements throughout the considered time period.
  • More specifically, the currency pair showed an upward movement from November 30th up to December 2nd.
  • From 3rd to 12th of December, the exchange rate fluctuated up and down, ending with a higher price range on December 14th.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Health Care: Acotec Scientific Holdings, Mankind Pharma, MicroPort NeuroTech, Respiri Ltd and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Acotec (6669 HK): Boston Scientific’s HK$20 Partial Offer Unconditional
  • Mankind Pharma Pre-IPO – The Negatives – Recent Updates Weren’t Great
  • MicroPort NeuroTech (2172.HK) – The Potential Risks Behind the Positive Profit Alert
  • Respiri – Trading recap highlights continued market traction

Acotec (6669 HK): Boston Scientific’s HK$20 Partial Offer Unconditional

By Arun George

  • As expected, Acotec Scientific Holdings (6669 HK)’s partial offer from Boston Scientific (BSX US) at HK$20 per share is now unconditional. The final closing date is 9 February.
  • The current acceptances representing 78.59% of outstanding shares imply current proration is 82.71%. Current pro-ration suggests CA Medtech post-offer shares will be counted towards the public float.
  • Based on the current proration of 82.71% and at the last close price of HK$19.78 per share, the breakeven price is HK$19.00 per share. 

Mankind Pharma Pre-IPO – The Negatives – Recent Updates Weren’t Great

By Sumeet Singh

  • Mankind Pharma is looking to raise about US$1bn in its upcoming India IPO.
  • MP is a pharmaceutical company engaged in developing, manufacturing and marketing a range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.
  • In this note, we talk about the not-so-positive aspects of the deal.

MicroPort NeuroTech (2172.HK) – The Potential Risks Behind the Positive Profit Alert

By Xinyao (Criss) Wang

  • The spring coil centralized procurement of neuro-interventional consumables in 21 provinces led by Jilin is about to start. The result may be unexpected, which could cause uncertainty to NeuroTech’s performance.
  • The promotion of import substitution in the field of neuro-intervention has not been as smooth as expected. If foreign brands win the bid, doctors would give priority to imported products.
  • Since NeuroTech is in leading position among domestic peers and has core R&D capabilities in this industry, we think it still has investment value. The valuation is in comfortable range.

Respiri – Trading recap highlights continued market traction

By Edison Investment Research

Respiri has released its Q223 quarterly activity report and provided a business update for the quarter. The second quarter was characterised by improving commercial traction for Respiri, with the company signing three new contracts for wheezo (including Minnesota Lung Center and Arkansas Heart Hospital), taking the total client count to six at the end of the period. Respiri’s wearable device Sorfe also continues to make progress with clinical studies anticipated to commence by March/April 2023. The recent announcement of a A$1.5m capital raise (with the option to increase the offering size based on investors interest) is expected to extend the company’s cash runway to Q423, based on current burn rates. With patient onboarding ongoing at multiple sites, we expect initial cash inflows from device sales and RPM services in the coming months, which should help scale up commercial activities and likely expand the cash runway further.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Financials: Jafco Co Ltd, NIFTY Index, S&P Global Inc., Korea Stock Exchange Kospi 200 Index, USD, Hang Seng China Enterprises Index and more

By | Daily Briefs, Financials

In today’s briefing:

  • JAFCO Tender Offer Results – Low Pro-Ration Surprise, Murakami Overhang
  • Nifty Index (NIFTY INDEX) Has Confirmed Multi-Month Downtrend Risk
  • S&P (SPGI US) VS S&P (SPX Index): A Leveraged Play on Rate Expectations
  • EQD | KOSPI2 Index: Buy Calls/​Call Spreads into CPI Release – Update
  • Comment on Exchange Rate EUR/USD – December 30, 2022
  • Hang Seng CEI (HSCEI) – High Probability Target at 9450/70 in 2023 (+20%)

JAFCO Tender Offer Results – Low Pro-Ration Surprise, Murakami Overhang

By Travis Lundy

  • Jafco Co Ltd (8595 JP) announced the results of its Tender Offer Buyback today. They wanted to buy 16.8mm shares including 13.9mm from Murakami-san. He sold 9.63mm. Oops. 
  • Pro-Ration was 69.25% which means that Murakami entities are still long about 4.276mm shares or 5.83% of shares out. 
  • There should be some index selling, and some Murakami Overhang. There may be more overhang at recent prices.

Nifty Index (NIFTY INDEX) Has Confirmed Multi-Month Downtrend Risk

By David Coloretti, CMT

  • At TMA we deliver high probability outcomes by focusing on our 3 pillars of technical analysis. 1) Response to key levels. 2) Price action. 3) Momentum confirmation.
  • Every recommendation requires definitive evidence of all 3 pillars to be regarded as a high probability outcome. 
  • The Nifty Index (NIFTY INDEX) delivered upon our 3 pillars in Nov/Dec 2022. A consecutive down month in January will be further evidence of a likely 15%-18% correction.

S&P (SPGI US) VS S&P (SPX Index): A Leveraged Play on Rate Expectations

By Stanley Tsai, CFA

  • S&P (the company) may be a lot more exposed than S&P (the index) if rates stay higher for longer and bets against the Fed unwind in 2H23.
  • While we like the rating agency and financial data provider’s business portfolio, valuation is looking a bit stretched based on fundamental, relative and technical valuation metrics.
  • We believe it is unlikely that the stock will push through the USD375/share resistance level in the near term, and would look for entry opportunities closer to USD325/share.

EQD | KOSPI2 Index: Buy Calls/​Call Spreads into CPI Release – Update

By Simon Harris

  • On Jan 19th we recommended a call and call spread to play upside in the KOSPI2 Index
  • Since then the market has rallied 3.75% and has moved through our first strikes
  • We look at restructuring the trades to play further momentum

Comment on Exchange Rate EUR/USD – December 30, 2022

By VRS (Valuation & Research Specialists)

  • The EUR/USD exchange rate has been moving upwards, as seen in Graph 1. There were four secondary movements throughout the considered time period.
  • More specifically, the currency pair showed an upward movement from November 30th up to December 2nd.
  • From 3rd to 12th of December, the exchange rate fluctuated up and down, ending with a higher price range on December 14th.

Hang Seng CEI (HSCEI) – High Probability Target at 9450/70 in 2023 (+20%)

By David Coloretti, CMT

  • On 26 January 2023 we published our bearish multi-month Nifty Index (NIFTY INDEX) outlook. For the RV player, the Hang Seng CEI (HSCEI) is likely to present material opportunity.
  • At TMA we place tremendous emphasis on momentum confirmation. Currently, LT momentum triggers confirm a sustainable multi-month to multi-quarter uptrend in the HSCEI.
  • Occasionally Fibonacci retracement levels, based off different portions of a trend, coincide. These create high probability targets. 9450/70 in the HSCEI is one such high probability target in 2023.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Consumer: Xingda International, Tesla Motors, OASIS Corp, ZJLD Group, Hindustan Unilever, Hyundai Motor, Takashimaya, Itochu Corp, Tata Motors Ltd and more

By | Consumer, Daily Briefs

In today’s briefing:

  • Xingda (1899 HK): HK$1.88 Partial Offer Now Open
  • Tesla Q4 Miss Is Big & Sets the Stage for a Drop in 2023 Profits
  • Oasis Corporation IPO – Thoughts on Valuation
  • ZJLD Group Pre-IPO Tearsheet
  • Hindustan Unilever (HUVR IN) | Royalty Rukus
  • Hyundai Motor: Solid Earnings in 4Q 2022 + Shares Cancellation
  • Record Sales at JR Tokai Takashimaya
  • Itochu Signs L.L.Bean License, Gears up Forever 21 and Eddie Bauer Relaunches
  • Tata Motors – Earnings Flash – Q3 FY 2022-23 Results – Lucror Analytics

Xingda (1899 HK): HK$1.88 Partial Offer Now Open

By Arun George

  • Xingda International (1899 HK)’s partial offer from a management-controlled offeror at HK$1.88 per share is now open. The IFA opines it to be fair and reasonable.
  • The partial offer is conditional on the offeror/concert parties, which have a 45.60% stake, hitting 50.01% voting rights and approval by the requisite majority of shareholders on the acceptance form.
  • The 4.41% minimum acceptance is not onerous. Based on a proration of 8.88% and at the last close price of HK$1.59 per share, the breakeven price is HK$1.56 per share.

Tesla Q4 Miss Is Big & Sets the Stage for a Drop in 2023 Profits

By SC Capital

  • Tesla reported a 6% Q4 EPS beat, but stripping out a one-off deferred revenue booking & higher than expected regulatory credits, Q4 results missed by 9%.  
  • Tesla rose +5.5% post market close after Musk said YTD orders are “2x” output. None of the data we have seen implies such demand, especially weekly China sales. 
  • What went unnoticed on the earnings call is that Tesla created a $7bn credit facility this month, which should dash all hopes of them doing a share buyback in 2023. 

Oasis Corporation IPO – Thoughts on Valuation

By Ethan Aw

  • OASIS Corp (370190 KS) is looking to raise up to US$166m in its upcoming Korea IPO.
  • Oasis Corporation is an early morning delivery service business that delivers fresh food to consumers. It runs an e-commerce platform named ‘Oasis Market’ as well as offline stores.
  • In our previous notes, we looked at the company’s past performance and peer comparison. In this note, we talk about valuations.

ZJLD Group Pre-IPO Tearsheet

By Clarence Chu

  • ZJLD Group (ZJLD HK) is looking to raise up to US$400m in its Hong Kong IPO. The deal will be run by Goldman Sachs and China Securities. 
  • ZJLD Group (ZJLD) is a Chinese liquor company primarily producing baijiu.
  • As per F&S, the firm was the fourth largest privately-owned baijiu company and ranked third among all baijiu companies with three or more aroma types in terms of FY21 sales. 

Hindustan Unilever (HUVR IN) | Royalty Rukus

By Pranav Bhavsar

  • Hindustan Unilever (HUVR IN)‘s strong quarterly performance was overshadowed by a proposed hike in royalty payments to parent Unilever PLC (ULVR LN) 
  • HUVR’s historical royalty growth has been below revenue and PBT growth and hence does not generate any red flags in terms of minority shareholder protection.  
  • While the impact on EPS is ~3%, we believe much of the reaction around HUVR’s Royalty is Noise. 

Hyundai Motor: Solid Earnings in 4Q 2022 + Shares Cancellation

By Douglas Kim

  • Hyundai Motor’s EV sales as a percentage of total sales increased from 4.3% in 4Q 2021 to 5.7% in 4Q 2022. 
  • Hyundai Motor announced that it will cancel 2.14 million common shares, representing 1% of its outstanding common shares.
  • The company beat consensus sales and operating profit estimates in 4Q 2022 and the consensus is likely to revise up their earnings estimates. 

Record Sales at JR Tokai Takashimaya

By Michael Causton

  • JR Takashimaya is a newbie in the world of department store retailing but has grown to become the fourth highest selling store in the two decades since it opened. 
  • As a result, it is increasingly regarded by brands as the Nagoyan version of Isetan Shinjuku in Tokyo and Hankyu Umeda in Osaka.
  • The store is an example of Takashimaya’s successful strategy to surround its key stores with more shopping facilities to suit all population segments, so driving traffic to the main store.

Itochu Signs L.L.Bean License, Gears up Forever 21 and Eddie Bauer Relaunches

By Michael Causton

  • Three years ago, Itochu Corp made it clear it would be investing heavily in its brand business.
  • It has been true to its word, adding the likes of Reebok, Under Armour and Forever 21 to its portfolio in the last year alone.
  • It has now signed a deal with long-term Japan operator, L.L.Bean, while gearing up for a major relaunch of Eddie Bauer.

Tata Motors – Earnings Flash – Q3 FY 2022-23 Results – Lucror Analytics

By Trung Nguyen

In our view, Tata Motors’ Q3/22-23 results were solid and much better than expected, especially in terms of profitability and cash flows. The strong performance was driven by gradual improvement in chip supply, cost savings, product mix and softer commodity prices. Guidance is also positive. The financial risk profile should improve, supported by significantly higher earnings and slightly lower debt. Liquidity, at least at Jaguar Land Rover (JLR), remains sound. JLR has no debt maturities until January 2024.

While Tata Motors will likely be able to deliver earnings improvement in H2/22-23, we believe it might be difficult for the company to achieve net-zero auto debt in two years as guided, considering the challenging operating environment. In this context, a revision of this target is warranted.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief South Korea: OASIS Corp, Hyundai Motor, Korea Stock Exchange Kospi 200 Index and more

By | Daily Briefs, South Korea

In today’s briefing:

  • Oasis Corporation IPO – Thoughts on Valuation
  • Hyundai Motor: Solid Earnings in 4Q 2022 + Shares Cancellation
  • EQD | KOSPI2 Index: Buy Calls/​Call Spreads into CPI Release – Update

Oasis Corporation IPO – Thoughts on Valuation

By Ethan Aw

  • OASIS Corp (370190 KS) is looking to raise up to US$166m in its upcoming Korea IPO.
  • Oasis Corporation is an early morning delivery service business that delivers fresh food to consumers. It runs an e-commerce platform named ‘Oasis Market’ as well as offline stores.
  • In our previous notes, we looked at the company’s past performance and peer comparison. In this note, we talk about valuations.

Hyundai Motor: Solid Earnings in 4Q 2022 + Shares Cancellation

By Douglas Kim

  • Hyundai Motor’s EV sales as a percentage of total sales increased from 4.3% in 4Q 2021 to 5.7% in 4Q 2022. 
  • Hyundai Motor announced that it will cancel 2.14 million common shares, representing 1% of its outstanding common shares.
  • The company beat consensus sales and operating profit estimates in 4Q 2022 and the consensus is likely to revise up their earnings estimates. 

EQD | KOSPI2 Index: Buy Calls/​Call Spreads into CPI Release – Update

By Simon Harris

  • On Jan 19th we recommended a call and call spread to play upside in the KOSPI2 Index
  • Since then the market has rallied 3.75% and has moved through our first strikes
  • We look at restructuring the trades to play further momentum

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Australia: Warrego Energy, Harvest Technology Group Ltd, Respiri Ltd and more

By | Australia, Daily Briefs

In today’s briefing:

  • Where To Go With Warrego?
  • HTG – EU Defence Force Needs Secure Communications
  • Respiri – Trading recap highlights continued market traction

Where To Go With Warrego?

By David Blennerhassett

  • It’s a fair bet Hancock Prospecting and Mineral Resources (MIN AU) are actively discussing the final stages for Warrego Energy (WGO AU) behind the scenes.
  • It is unlikely MinRes aggressively builds a ~19% stake in a company subject to a two-way takeover battle, and declares its position “strategic” with no intention of making an Offer. 
  • This stake may be a bargaining chip from MinRes to keep Hancock on the sidelines in its tilt for Norwest Energy NL (NWE AU).

HTG – EU Defence Force Needs Secure Communications

By Research as a Service (RaaS)

  • Harvest Technology Group Limited (ASX:HTG) licenses its proprietary video compression and encryption technology for low-bandwidth, high-latency applications needing secure real-time streaming video communication.
  • The company delivers solutions for data transfer from anywhere via satellite or congested networks.
  • Harvest offers a solution which enables real-time monitoring of remote locations, real-time feedback for field technicians, and secure video conferencing. 

Respiri – Trading recap highlights continued market traction

By Edison Investment Research

Respiri has released its Q223 quarterly activity report and provided a business update for the quarter. The second quarter was characterised by improving commercial traction for Respiri, with the company signing three new contracts for wheezo (including Minnesota Lung Center and Arkansas Heart Hospital), taking the total client count to six at the end of the period. Respiri’s wearable device Sorfe also continues to make progress with clinical studies anticipated to commence by March/April 2023. The recent announcement of a A$1.5m capital raise (with the option to increase the offering size based on investors interest) is expected to extend the company’s cash runway to Q423, based on current burn rates. With patient onboarding ongoing at multiple sites, we expect initial cash inflows from device sales and RPM services in the coming months, which should help scale up commercial activities and likely expand the cash runway further.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars